[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100510459":3},{"organization":4,"armGroups":7,"interventions":15,"overallOfficials":27,"centralContacts":32,"locations":39,"responsibleParty":54,"collaborators":21,"id":56,"slug":57,"hasResults":58,"nctId":59,"briefTitle":60,"officialTitle":61,"acronym":21,"eligibilityCriteria":62,"healthyVolunteers":58,"sex":63,"minAge":21,"maxAge":21,"enrollmentInfo":64,"targetDuration":21,"studyType":67,"phases":68,"briefSummary":70,"conditions":71,"keywords":21,"overallStatus":42,"whyStopped":21,"lastUpdateSubmitDate":75,"lastUpdatePostDateStruct":76,"startDateStruct":79,"completionDateStruct":81,"leadSponsor":83,"locationsCount":84},{"fullName":5,"class":6},"Orient Europharma Co., Ltd.","INDUSTRY",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"nutritional supplements and supervised exercise on Sarcopenia group and Severe Sarcopenia group","EXPERIMENTAL","The intervention consisted of providing nutritional supplements and supervised exercise for 12 weeks. After the intervention (the 12th week), the trial commissioned company provides nutritional supplements with a market price of about NT$4,000 per month for three months free to participants who are willing to continue taking the products. Those participants will be tracked for one year.",[13,14],"Dietary Supplement: Sarcojoint®","Behavioral: supervised exercise",[16,22],{"type":17,"name":18,"description":19,"armGroupLabels":20,"otherNames":21},"DIETARY_SUPPLEMENT","Sarcojoint®","All participants are administered Sarcojoint® containing leucinine 1 g, arginine 1.5 g, Vitamin D 7.5μg, chondroitin 400 mg, calcium 300 mg, and glucosamine 700 mg per package, and take 1 package twice a day.",[9],null,{"type":23,"name":24,"description":25,"armGroupLabels":26,"otherNames":21},"BEHAVIORAL","supervised exercise","All participants are required to walk 6500 steps every day for 12 weeks, and the data are recorded by Xiaomi-smart-band.",[9],[28],{"name":29,"affiliation":30,"role":31},"Pin-Kuei Fu","Department of Chest Medicine of Taichung Veterans General","PRINCIPAL_INVESTIGATOR",[33],{"name":34,"role":35,"phone":36,"phoneExt":37,"email":38},"Pin-Kuei Fu, PhD","CONTACT","04-23592525","6536","yetquen@vghtc.gov.tw",[40],{"facility":41,"status":42,"city":43,"state":21,"zip":21,"country":44,"countryCode":45,"cosmosGeoPoint":46,"geoPoint":51,"contacts":52},"Taichung Veterans General Hospital","RECRUITING","Taichung","Taiwan","TW",{"type":47,"coordinates":48},"Point",[49,50],120.6839,24.1469,{"lat":50,"lon":49},[53],{"name":34,"role":35,"phone":36,"phoneExt":37,"email":38},{"type":55,"investigatorFullName":21,"investigatorTitle":21,"investigatorAffiliation":21,"oldNameTitle":21,"oldOrganization":21},"SPONSOR","100510459","evaluate-the-effect-of-dietary-supplement-combined-exercise-among-patients-with-sarcopenia-comorbid-with-lung-disease-100510459",false,"NCT05926713","Evaluate the Effect of Dietary Supplement Combined Exercise Among Patients With Sarcopenia Comorbid With Lung Disease","Evaluate the Effect of Dietary Supplement Combined Supervised Exercise on Physical Performance and Body Composition Among Patients With Sarcopenia and Severe Sarcopenia Comorbid With COPD or ILD: A Prospective, Multi-center Cohort Study","Inclusion Criteria:\n\n* Outpatients with COPD (chronic obstructive pulmonary disease) or ILD (interstitial lung disease) from Department of Chest medicine in Taichung Veterans General Hospital, judged by the doctor that they do not need hospitalization or emergent treatment.\n* Outpatients who meet the diagnostic criteria for Sarcopenia after evaluation by a physician.\n\nExclusion Criteria:\n\n* Patients who refuse to sign the consent form\n* Patients who are under 20 years old\n* Patients who are bedridden or unable to walk due to physical disabilities\n* Patients with terminal cancer or human-acquired immunodeficiency syndrome\n* Patients with edema (grading pitting edema +2)","ALL",{"count":65,"type":66},100,"ESTIMATED","INTERVENTIONAL",[69],"NA","This trial is a prospective multi-center study. The purpose of this study is to evaluate the effect of dietary supplement combined with supervised exercised on the physical performance, body composition and lung function among patients with Sarcopenia and severe Sarcopenia in chronic lung disease. After participants enroll in this study, 12-week clinical trial will be conducted to analyze the improvement regarding Sarcopenia and different severity of Sarcopenia before and after the intervention of exercise and nutritional products, which can further provide reference for clinical intervention and rehabilitation.",[72,73,74],"Sarcopenia","COPD","ILD","2023-06-21",{"date":77,"type":78},"2023-07-03","ACTUAL",{"date":80,"type":78},"2023-03-01",{"date":82,"type":66},"2032-10-31",{"name":5,"class":6},1]